An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia

20Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Tyrosine kinase inhibitors have profoundly modified the treatment and prognosis of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia. A rapid and accurate detection of the BCR-ABL fusion protein is paramount today for an optimal management of Ph+ acute lymphoblastic leukemia. We have utilized a recently described and commercialized immunoassay that identifies qualitatively the presence of the BCR-ABL protein in leukemic cell lysates. The BCR-ABL fusion protein is captured and detected by a cytometric bead assay and analyzed by flow cytometry. The assay was applied to 101 primary patient samples (94 acute leukemias and 7 chronic myeloid leukemia blast crisis) and the results of the immunoassay were concordant with those obtained by conventional molecular techniques. The method proved reliable, reproducible, of simple execution and it was successfully completed within four hours. This flow cytometric immunoassay has important implications for perfecting the management of Ph+ acute lymphoblastic leukemia patients worldwide. ©2009 Ferrata Storti Foundation.

References Powered by Scopus

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

1110Citations
N/AReaders
Get full text

The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype

644Citations
N/AReaders
Get full text

Translation of the Philadelphia chromosome into therapy for CML

610Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

393Citations
N/AReaders
Get full text

Multiparametric flow cytometry for MRD monitoring in hematologic malignancies: Clinical applications and new challenges

40Citations
N/AReaders
Get full text

Monitoring of minimal residual disease (Mrd) in chronic myeloid leukemia: Recent advances

35Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Raponi, S., De Propris, M. S., Wai, H., Intoppa, S., Elia, L., Diverio, D., … Guarini, A. (2009). An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia. Haematologica, 94(12), 1767–1770. https://doi.org/10.3324/haematol.2009.010900

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

43%

Researcher 9

39%

Professor / Associate Prof. 2

9%

Lecturer / Post doc 2

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

50%

Biochemistry, Genetics and Molecular Bi... 6

27%

Agricultural and Biological Sciences 4

18%

Design 1

5%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free